Recursion CFO has 5,396 shares withheld for taxes

RXRX’s CFO had shares withheld to cover taxes on vested RSUs, with no open-market sale and over 1.07 million shares still held directly.

Rhea-AI Filing Summary

RECURSION PHARMACEUTICALS, INC. (RXRX) reported that Chief Financial Officer Ben R Taylor had 5,396 shares of Class A Common Stock withheld on September 15, 2026 to satisfy tax withholding obligations tied to the net settlement of restricted stock units. These shares were not sold on the market. Following this withholding, Taylor directly holds 1,071,462 shares of Class A Common Stock.

Insider Trade Summary

Tax Withholding: 5,396 shares

Tax Withholding 1 txn

Insider Taylor Ben R

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Class A Common Stock F1	5,396	$3.41	$18K

Holdings After Transaction: Class A Common Stock — 1,071,462 shares (Direct)

Footnotes (1)

1. F1. Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.

Key Figures

Shares withheld for taxes: 5,396 shares Withholding reference price: $3.41 per share Shares held after transaction: 1,071,462 shares +1 more

4 metrics

Shares withheld for taxes 5,396 shares Class A Common Stock withheld on September 15, 2026 to satisfy tax withholding on RSUs

Withholding reference price $3.41 per share Value used for the tax-withholding disposition of 5,396 shares

Shares held after transaction 1,071,462 shares Direct Class A Common Stock holdings by CFO Ben R Taylor after the withholding

Transaction date September 15, 2026 Date of the tax-withholding disposition reported on Form 4

Key Terms

restricted stock units, net settlement, tax withholding

3 terms

restricted stock units financial

"in connection with the net settlement of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

net settlement financial

"in connection with the net settlement of restricted stock units"

tax withholding financial

"withheld by the Issuer to satisfy its tax withholding and remittance"

Tax withholding is the practice of taking a portion of a payment—such as wages, dividends, or sale proceeds—before it reaches the recipient and sending that portion to the tax authority as an advance on the recipient’s eventual tax bill. For investors it matters because withholding reduces immediate cash received and affects after‑tax returns, estimated tax payments, and whether you may owe more or receive a refund when taxes are finally calculated, like having a small automatic savings set aside for your tax bill.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did RXRX’s CFO report on September 15, 2026?

Ben R Taylor, RXRX’s Chief Financial Officer, reported that 5,396 shares of Class A Common Stock were withheld on September 15, 2026 to satisfy tax withholding obligations related to restricted stock units, rather than sold in the open market.

How many RXRX shares does the CFO hold after this Form 4 transaction?

After the tax-related withholding, CFO Ben R Taylor directly holds 1,071,462 shares of Recursion Pharmaceuticals Class A Common Stock, as reported in the Form 4 filing.

Was the RXRX CFO’s Form 4 transaction an open-market sale?

No. The filing states the 5,396 shares were withheld by the issuer to satisfy tax withholding and remittance obligations for net settlement of restricted stock units, and not sold in the open market.

What price per share is associated with the RXRX CFO’s tax-withholding transaction?

The shares withheld to cover taxes for RXRX’s CFO are reported at $3.41 per share, which is used to determine the value of the tax withholding in connection with the restricted stock units.

Was a Rule 10b5-1 trading plan involved in the RXRX CFO’s transaction?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed, and the transaction is characterized as shares withheld by the issuer to cover tax obligations, not trades under a 10b5-1 plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 05:52 PM Accepted by SEC EDGAR 09/16/2026 - 05:52 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taylor Ben R

(Last) (First) (Middle)

41 S. RIO GRANDE STREET

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RECURSION PHARMACEUTICALS, INC. [ RXRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/15/2026		F(1)		5,396	D	$3.41	1,071,462	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.

Remarks:

	/s/ Kyle Nelson, attorney-in-fact	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)